LIPANTHYL® 145 145mg/tablet Spojené arabské emiráty - angličtina - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

lipanthyl® 145 145mg/tablet

al phamed co.abudhabi ltd.llc united arab emirates - 30's (10's blister x 3) - tablet - 145mg/tablet - cardiovascular system-lipid-regulators

Lipanthyl 200 mg Namíbia - angličtina - Namibia Medicines Regulatory Council

lipanthyl 200 mg

abbott laboratories (pty) ltd - fenofibrate - capsule - each capsule contains fenofibrate (micronised) 200,0 mg

PMS-FENOFIBRATE MICRO CAPSULE Kanada - angličtina - Health Canada

pms-fenofibrate micro capsule

pharmascience inc - fenofibrate - capsule - 200mg - fenofibrate 200mg - fribic acid derivatives

LIPIDIL MICRO CAPSULE Kanada - angličtina - Health Canada

lipidil micro capsule

bgp pharma ulc - fenofibrate - capsule - 200mg - fenofibrate 200mg - fribic acid derivatives

Lipantil Micro 200 mg capsules, hard Írsko - angličtina - HPRA (Health Products Regulatory Authority)

lipantil micro 200 mg capsules, hard

primecrown 2010 limited - fenofibrate - capsule, hard - 200 milligram(s) - fibrates; fenofibrate - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: severe hypertriglyceridaemia with or without low hdl cholesterol, mixed hyperlipidaemia when a statin is contraindicated or not tolerated, mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Lipantil Micro 200mg capsules, hard. Írsko - angličtina - HPRA (Health Products Regulatory Authority)

lipantil micro 200mg capsules, hard.

bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.